These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33271290)

  • 41. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
    Wang B; Van Oekelen O; Mouhieddine TH; Del Valle DM; Richter J; Cho HJ; Richard S; Chari A; Gnjatic S; Merad M; Jagannath S; Parekh S; Madduri D
    J Hematol Oncol; 2020 Jul; 13(1):94. PubMed ID: 32664919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome.
    Real de Asua D; Mayer MA; Ortega MDC; Borrel JM; Bermejo TJ; González-Lamuño D; Manso C; Moldenhauer F; Carmona-Iragui M; Hüls A; Sherman SL; Strydom A; de la Torre R; Dierssen M
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study.
    Liu R; Zhao L; Cheng X; Han H; Li C; Li D; Liu A; Gao G; Zhou F; Liu F; Jiang Y; Zhu C; Xia Y
    Liver Int; 2021 Apr; 41(4):720-730. PubMed ID: 33351265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System.
    Ku JH; Levin MJ; Luo Y; Florea A; Lin IC; Tian Y; Tseng HF
    J Infect Dis; 2022 Sep; 226(5):757-765. PubMed ID: 35749312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID 19 - Possible interrelations with respiratory comorbidities caused by occupational exposure to various hazardous bioaerosols. Part I. Occurrence, epidemiology and presumed origin of the pandemic.
    Dutkiewicz J; Mackiewicz B; Lemieszek MK
    Ann Agric Environ Med; 2020 Dec; 27(4):491-504. PubMed ID: 33356052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
    Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
    Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19.
    Kim ES; Chin BS; Kang CK; Kim NJ; Kang YM; Choi JP; Oh DH; Kim JH; Koh B; Kim SE; Yun NR; Lee JH; Kim JY; Kim Y; Bang JH; Song KH; Kim HB; Chung KH; Oh MD;
    J Korean Med Sci; 2020 Apr; 35(13):e142. PubMed ID: 32242348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database.
    Dong X; Zhou Y; Shu XO; Bernstam EV; Stern R; Aronoff DM; Xu H; Lipworth L
    Microbiol Spectr; 2021 Sep; 9(1):e0032721. PubMed ID: 34406805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of "the New Normal with COVID-19".
    Imai K; Tanaka H
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetics of viral load and antibody response in relation to COVID-19 severity.
    Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
    J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Defective Immune Response to SARS-CoV-2 Immunization in Down Syndrome Correlates With Increased Susceptibility to Severe Illness With Infection.
    Atkinson TP
    J Infect Dis; 2022 Sep; 226(5):755-756. PubMed ID: 35749348
    [No Abstract]   [Full Text] [Related]  

  • 53. COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey.
    Emes D; Hüls A; Baumer N; Dierssen M; Puri S; Russell L; Sherman SL; Strydom A; Bargagna S; Brandão AC; Costa ACS; Feany PT; Chicoine BA; Ghosh S; Rebillat AS; Sgandurra G; Valentini D; Rohrer TR; Levin J; Lakhanpaul M; On Behalf Of The Trisomy Research Society Covid-Initiative Study Group
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple Organ Failure Associated with SARS-CoV-2 Infection in a Child with Down Syndrome: Is Trisomy 21 Associated with an Unfavourable Clinical Course?
    Vazquez-Hernández PI; Cárdenas-Conejo A; Catalán-Ruiz MA; Navar-Gallegos K; Zenteno-Salazar E; Rafael-Parra-Bravo J; Aragon-Nogales R; Ibarra-Sarlat M; Núñez-Enríquez JC
    Case Rep Pediatr; 2021; 2021():5893242. PubMed ID: 34760326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 infection and Down syndrome-challenges and future directions for care in children.
    Chauhan K; Alkhaldi R; Chatterjee S
    Neurol Sci; 2022 Sep; 43(9):5181-5182. PubMed ID: 35767087
    [No Abstract]   [Full Text] [Related]  

  • 56. The immune system in Down Syndrome: Autoimmunity and severe infections.
    Ramba M; Bogunovic D
    Immunol Rev; 2024 Mar; 322(1):300-310. PubMed ID: 38050836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey.
    Pinku H; Hüls A; Feany PT; Baumer N; Dierssen M; Bargagna S; Costa AC; Chicoine BA; Rebillat AS; Sgandurra G; Valentini D; Rohrer RT; Levin J; Lakhanpaul M; Carfì A; Sherman SL; Strydom A; Ghosh S;
    J Glob Health; 2022 Aug; 12():05035. PubMed ID: 35932238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Down Syndrome and COVID-19: not always a poor prognosis.
    Parisini A; Boni S; Vacca EB; Del Puente F; Feasi M; Bobbio N; Prinapori R; Bolla C; Castellaneta M; Pontali E; Chichino G
    Int J Tuberc Lung Dis; 2022 Jul; 26(7):691-693. PubMed ID: 35768929
    [No Abstract]   [Full Text] [Related]  

  • 59. An international survey on the impact of COVID-19 in individuals with Down syndrome.
    Hüls A; Costa ACS; Dierssen M; Baksh RA; Bargagna S; Baumer NT; Brandão AC; Carfi A; Carmona-Iragui M; Chicoine BA; Ghosh S; Lakhanpaul M; Manso C; Mayer MA; Del Carmen Ortega M; de Asua DR; Rebillat AS; Russell LA; Sgandurra G; Valentini D; Sherman SL; Strydom A
    medRxiv; 2020 Nov; ():. PubMed ID: 33173907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 infection in patients with Sézary syndrome: Report of two cases.
    Gonzaga Y; Santos MBF; Silva MM; Nucci M
    Dermatol Ther; 2020 Nov; 33(6):e14042. PubMed ID: 32700814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.